Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.68 |
| ▸ | TP53 | P04637 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | CA12 | O43570 | 1/20 | 0.68 |
| ▸ | CA1 | P00915 | 1/20 | 0.68 |
| ▸ | CA2 | P00918 | 1/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.68 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.68 |
| ▸ | AR | P10275 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.68 |
| ▸ | CA9 | Q16790 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31675811 | 1.00 | NMUR2 (0.71) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL471860 | 0.90 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL3062193 | 0.86 | KDM4E (0.72) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL6834225 | 0.85 | MEN1 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL1423153 | 0.85 | NMUR2 (0.54) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL5425962 | 0.84 | MEN1 (0.66) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL773152 | 0.83 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL157971 | 0.83 | KDM4E (0.64) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL15676117 | 0.83 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL16586869 | 0.83 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1036 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038960-A1 | OLIGONUCLEOTIDES CONTAINING A LIGAND AT AN INTERNAL POSITION | ADARX PHARMACEUTICALS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| CN-118085410-A | Boron-based natural flavone brucite composite powder and preparation method and application thereof | 江西广源新材料有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117562060-A | Temperature intelligent sensing algae-inhibiting flavone slow-release microsphere and preparation method thereof | 浙江大学 | 2024-02-20 | — | — | CN | claimed |
| CN-117562061-A | PH value intelligent sensing algae-inhibiting flavone slow-release microsphere and preparation method thereof | 浙江大学 | 2024-02-20 | — | — | CN | claimed |
| CN-115364006-B | Anti-aging barrier repairing composition and anti-aging barrier repairing skin care product | 皓雨(广州)化妆品制造有限公司 | 2024-02-09 | — | — | CN | claimed |
| WO-2024026037-A1 | ER-BETA ESTROGENIC COMPOUNDS AND METHODS OF USE | IATERION, INC. (US) | 2024-02-01 | — | — | WO | claimed |
| WO-2023150072-A1 | COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER | SINCLAIR DAVID A (US) | 2023-08-10 | — | — | WO | claimed |
| CN-114958730-A | Muscle stem cell proliferation medium, differentiation medium and application thereof | 南京农业大学 | 2022-08-30 | — | — | CN | claimed |
| US-20220249431-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2022-08-11 | — | — | US | claimed |
| EP-4003522-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2022-06-01 | — | — | EP | claimed |
| WO-2003035897-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| US-6329422-B1 | ENHANCING, STIMULATING CHLORIDE TRANSPORT IN EPITHELIAL CELLS; FLAVONE OR ISOFLAVONE OR A STEREOISOMER THEREOF. | CHILDREN'S HOSPITAL OAKLAND RESEARCH INSTITUTE | 2001-12-11 | — | — | US | claimed |
| WO-2001080855-A1 | TELOMERASE INHIBITORS AND METHODS OF THEIR USE | GERON CORPORATION (US) | 2001-11-01 | — | — | WO | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| EP-1024803-A1 | FLAVONOIDS FOR CYSTIC FIBROSIS THERAPY | Children's Hospital Medical Center of Northern California (US) | 2000-08-09 | — | — | EP | claimed |
| WO-1999018953-A1 | FLAVONOIDS FOR CYSTIC FIBROSIS THERAPY | CHILDREN'S HOSPITAL MEDICAL CENTER OF NORTHERN CALIFORNIA (US) | 1999-04-22 | — | — | WO | claimed |
| EP-0245931-A2 | Nodulation inducing factors | LUBRIZOL GENETICS INC. (US) | 1987-11-19 | — | — | EP | claimed |
| EP-0024731-B1 | A PHOTOSTABLE ANTHOCYANIC COLORANT COMPOSITION AND ITS USE IN A FOOD COMPOSITION | THE COCA-COLA COMPANY (US) | 1983-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220249431-A1 | ANTIMYCOTIC | ETF1, FOXM1, RIF1 | NMUR2 4053/4885KDM4E 1705/4885MEN1 1320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.